2,353
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy

, , , , , , , , , , , , & show all
Article: e1376156 | Received 26 Jun 2017, Accepted 30 Aug 2017, Published online: 31 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Edgardo S. Santos. (2020) Treatment options after first-line immunotherapy in metastatic NSCLC. Expert Review of Anticancer Therapy 20:3, pages 221-228.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now

Articles from other publishers (10)

Akira Sakamoto, Hiroyuki Inoue, Shohei Miyamoto, Shun Ito, Yasushi Soda & Kenzaburo Tani. (2023) Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer. Scientific Reports 13:1.
Crossref
Hongjian Yang, Yuxi Miao, Zhaojin Yu, Minjie Wei & Xue Jiao. (2023) Cell adhesion molecules and immunotherapy in advanced non-small cell lung cancer: Current process and potential application. Frontiers in Oncology 13.
Crossref
Davood Bashash, Zahra Zandi, Bahareh Kashani, Atieh Pourbagheri‐Sigaroodi, Sina Salari & Seyed H. Ghaffari. (2021) Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities. Journal of Cellular Physiology 237:1, pages 346-372.
Crossref
Mona Yazdani, Zahra Gholizadeh, Amin Reza Nikpoor, Nema Mohamadian Roshan, Mahmoud Reza Jaafari & Ali Badiee. (2021) Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy. Scientific Reports 11:1.
Crossref
Mona Yazdani, Zahra Gholizadeh, Amin Reza Nikpoor, Mahdi Hatamipour, Behrang Alani, Hossein Nikzad, Nema Mohamadian Roshan, Javad Verdi, Mahmoud Reza Jaafari, Mahdi Noureddini & Ali Badiee. (2020) Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma. Vaccine 38:35, pages 5665-5677.
Crossref
Weilin Liu, Enyong Dai, Zuqiang Liu, Congrong Ma, Zong Sheng Guo & David L. Bartlett. (2020) In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2. Molecular Therapy - Oncolytics 17, pages 350-360.
Crossref
Wei Zhang, Hongyan Shu, Lixin Fang, Ning Tang, Yucai Li, Bingrong Guo & Fanhui Meng. (2020) Cancer inhibition mechanism of lung cancer mouse model based on dye trace method. Saudi Journal of Biological Sciences 27:4, pages 1155-1162.
Crossref
Yonghui Zhang, Hailin Zhang, Mei Wei, Tao Mou, Tao Shi, Yanyu Ma, Xinyu Cai, Yunzheng Li, Jie Dong & Jiwu Wei. (2019) Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC. Molecular Therapy 27:11, pages 1906-1918.
Crossref
Xingxiang Pu, Lin Wu, Dan Su, Weimin Mao & Bingliang Fang. (2018) Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance. BMC Cancer 18:1.
Crossref
Stacy J. Kowalsky, Zuqiang Liu, Mathilde Feist, Sara E. Berkey, Congrong Ma, Roshni Ravindranathan, Enyong Dai, Edward J. Roy, Zong Sheng Guo & David L. Bartlett. (2018) Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade. Molecular Therapy 26:10, pages 2476-2486.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.